Clinical Trials Browser

Phase 4 × OTHER × Safety × Clear all

NCT02277847 2014-10-29

Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia

Phase 4 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute